Your Notifications
All done, no notifications

About Dr. Professor Han Baohui

  • Professor Han Baohui is a nationally and internationally recognized expert in lung cancer diagnosis and treatment, serving as Honorary Vice Dean, Academic Leader, Chief Physician, Professor, and Doctoral Supervisor.
  • With over 40 years of clinical and research experience, he is one of the pioneers of lung cancer targeted therapy and immunotherapy in China.
  • Professor Han has played a key role in shaping lung cancer treatment standards, advancing precision oncology, and leading landmark clinical trials that have transformed the management of advanced lung cancer.
  • His work bridges clinical excellence, academic leadership, and pharmaceutical innovation.

Conditions treated by Professor Han Baohui

  • Non-small cell lung cancer (NSCLC)
  • Small cell lung cancer (SCLC)
  • Early and advanced-stage lung cancer
  • Complex pulmonary nodules
  • Metastatic lung tumors
  • Refractory and relapsed lung cancer
  • Other thoracic malignancies

Area of Interest

  • Non-small cell lung cancer (NSCLC)
  • Small cell lung cancer (SCLC)
  • Early and advanced-stage lung cancer
  • Complex pulmonary nodules
  • Metastatic lung tumors
  • Refractory and relapsed lung cancer
  • Other thoracic malignancies

Qualification

  • PhD (pulmonology), Zhongshan Clinical Medical College of Fudan University (1994)

Work Experiences

  • Former Vice President, Shanghai Chest Hospital
  • Former Director, Department of Respiratory Medicine
  • Director, Shanghai Thoracic Oncology Institute
  • Global Team of Board Certified Surgeons and Medical Specialists
  • Written Second Opinion report delivered within 5 days
  • Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Telemedicine Doctors

Do you know?

You can book a video consultation with Dr. Professor Han Baohui on our platform

CERTIFICATIONS (1)

  • Postdoctoral fellowship in tumor immunotherapy (USA)

MEMBERSHIPS (14)

  • Vice President and Chairman, Oncology Branch, Asia-Pacific Society for Medical and Biological Immunology
  • Executive Chairman, Chinese Lung Cancer Institute
  • CFDA (China Food and Drug Administration) Review Expert
  • Former Chairman, CSCO Tumor Angiography Targeted Therapy Committee
  • Vice Chairman, CSCO Non-Small Cell Lung Cancer Committee
  • Executive Committee Member, National Cancer Clinical Collaboration Center, Chinese Anti-Cancer Association
  • Chairman, Precision Oncology Diagnosis and Treatment Committee, China Primary Health Care Fund
  • Vice Chairman, Precision Oncology Treatment Committee, Chinese Anti-Cancer Association
  • Standing Committee Member, Respiratory Branch, Chinese Medical Association
  • Standing Committee Member, Oncology Branch, Chinese Medical Doctor Association
  • Director, Clinical Trial Institution for Drugs, Shanghai Chest Hospital
  • Vice Chairman, Shanghai Medical Association Oncology Target Molecular Society
  • Vice Chairman, Eighth Council, Shanghai Anti-Cancer Association
  • Chief Consultant, Tumor Chemotherapy Branch, Shandong Anti-Cancer Association

RESEARCH PAPERS AND PUBLICATIONS (2)

  • Published 100+ papers in leading international journals including: New England Journal of Medicine (NEJM), JAMA Oncology, and Lancet Oncology
  • Co-authored 10+ medical monographs

Share Your Experience about Dr. Professor Han Baohui

PROCEDURES

  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy

FREQUENTLY ASKED QUESTIONS

Is Professor Han Baohui doing teleconsultation on the MediGence platform?
Professor Han Baohui is available to teleconsult on the MediGence platform.
How long is the consultation?
The consultation typically lasts between 15 and 30 minutes. It may exceed the estimated time, depending on the patient’s queries and the doctor's medical suggestions.
How soon can the consultation be organised?
We have Medical specialists and board-certified doctors on our panel. The consultation will be organised within 24 to 48 hours, or based on the doctor's and patient's availability.
Is a follow-up consultation included in the consultation price?
No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.
How do I share my medical record with the doctor for review?
The option to share your medical records is available at the form steps on the website.
Can I book my procedure with the doctor post-consultation?
Yes. If you are satisfied with the consultation, you can proceed with treatment packages tailored to your diagnosis, assisted by our case managers.
Can you get an estimate for the procedure?
Yes. The cost estimate will be provided to you by our case manager, which will include the doctor’s opinion, the cost estimate, and crucial information about travelling to your medical destination.

FAQ's Related to Medical Oncologist

What is a Lung Cancer Expert?
Lung cancer experts specialise in diagnosing and treating lung cancers and have access to all available treatment modalities, including chemotherapy, targeted therapies, immunotherapies, and other collaborative treatments.
What is Precision Oncology in Lung Cancer Treatment?
By performing genetic and molecular testing on patients with lung cancer, Precision Oncology aims to identify the most effective treatment option (targeted or immunotherapy) for each patient.
What Constitutes Complex Nodules of the Lung?
Complex lung nodules are any abnormal growths or spots seen in the lungs that require additional imaging, biopsy, and specialist review to determine if they represent benign (not cancerous) or malignant ( cancerous) disease.
What Role Do Multidisciplinary Treatment Programs Play in Lung Cancer?
A Multidisciplinary Treatment Program offers a comprehensive approach to managing patients with lung cancer by providing a unified clinical treatment plan that draws on the expertise and resources of multiple disciplines, including oncology, pulmonary medicine, surgical management, radiology, and pathology.
Do Clinical Trials Offer Significant Benefits for Patients with Lung Cancer?
Yes! Clinical Trials provide opportunities to access novel cancer therapies, which often represent cutting-edge treatment technologies available to patients with lung cancer who may have complex or advanced disease.

Reviewer

Dr. Vishwas Kaushik
Dr. Vishwas Kaushik

MBBS, MD

7 Years of Experience

Dr. Vishwas Kaushik is a qualified medical professional holding an MBBS from the prestigious Belgorod State University, Russia, with a strong foundation in clinical medicine and healthcare practice. His comprehensive medical training has equipped him with a profound understanding of evidence-based clinical practices, patient-centered care, and the evolving landscape of modern medicine. With a keen interest in medical research and scientific communication, he consistently translates complex clinical concepts into clear, accurate, and accessible content for diverse audiences. His work reflects a deep commitment to advancing medical knowledge, delivering impactful healthcare insights, and bridging the gap between clinical expertise and accessible medical communication. View More

Last Reviewed - January 2026

Author

Dr. Shagufta Parveen
Dr. Shagufta Parveen

Doctor of Pharmacy

3 Years of Experience

Dr. Shagufta Parveen is a Clinical researcher and medical writer with expertise in clinical pharmacology and pharmacotherapeutics. She holds a B.Pharm and Doctor of Pharmacy (Post-Baccalaureate) degree from Teerthanker Mahaveer University, Moradabad.

During her clinical stint at BLK-Max Super Speciality Hospital and Indraprastha Apollo Hospital, she gained hands-on experience in the Clinical Pharmacology Department. Combining scientific knowledge with strong medical writing skills, Dr. Shagufta develops evidence-based healthcare content, treatment guides, and patient education resources.

Her work focuses on simplifying complex medical concepts while maintaining scientific accuracy, helping readers better understand healthcare advancements and treatment options.

In addition to her writing expertise, she is actively involved in scientific research and has contributed to peer-reviewed publications.

Her research work is accessible through the following links:

https://scholar.google.com/citations?user=lMVK1eIAAAAJ&hl=en

https://carcinogenesis.com/index.php/JOC/article/view/870

https://carcinogenesis.com/index.php/JOC/article/view/868

https://wjpsronline.com/abstract/0000000760

. View More